cancer%20pain
CANCER PAIN
Cancer pain is an unpleasant sensory & emotional experience due to actual or potential tissue damage in patients with cancer.
Effective pain management in cancer patients with pain is an essential part of oncologic management due to increasing evidence of survival.
Pancreatic, head & neck cancer has a high prevalence of cancer pain.
During initial evaluation, follow-ups and new therapy initiation of patients with cancer, it is essential that they will be screened & evaluated for pain.

Cancer%20pain Management

Follow Up

  • To ensure that the selected analgesic therapy has given the patient maximum benefit with as few adverse effects as possible, reassessment of pain intensity must be done at specified intervals
  • Patients on long-term opioid therapy should be assessed for abuse, addiction, tolerance or dependence
  • Consider opioid dose reduction by 10-20% in the following situations:
    • Breakthrough analgesic was rarely or never needed
    • Acute pain event has been completed
    • Improvement of pain control through use of non-opioid pain management therapies is evident
    • Well-controlled pain in the setting of stable disease
  • Opioid reduction by 10-25% can be considered in patients with unmanageable adverse effects and mild pain
    • Re-evaluate after dose reduction and have a close follow-up to make sure there is no pain escalation or withdrawal symptoms despite the dose reduction
  • Opioid reduction by 50-75% is necessary in patients who have significant safety issues

Specialist Referral

  • Patients may be referred to a psychiatrist for psychological support, or to a substance abuse specialist for patients on long-term opioid therapy with signs of drug addiction, abuse, dependence or tolerance
  • Consider physical or occupational therapy consultation for advice on the use of physical modalities
  • Orthopedic consultation should be considered in patients experiencing pain
  • Referral to a pain or palliative care specialist for refractory symptoms or intractable pain or for guidance on Methadone prescribing is recommended
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Oncology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Jun 2020
Drawing from experience as a key investigator in landmark clinical trials (including PALOMA, MONALEESA and MONARCH), and his clinical experience with CDK4/6 inhibitors, Dr Rafael Villanueva Vázquez shares his insights into the current evidence of using CDK4/6 inhibitors to treat HR+/HER2- ABC.